Close

Roth Capital Starts Galmed Pharmaceuticals (GLMD) at Buy, PT $20

April 15, 2015 6:52 AM EDT Send to a Friend
Roth Capital initiated coverage on Galmed Pharmaceuticals (NASDAQ: GLMD) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login